reading API source threads from 2024 and half of it aged badly
Been lurking in c/trialwatch for about 9 months and finally have something worth posting.
Short version: week 3, 2.4mg, and compounding is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 25 threads, and the answers split roughly down the middle.
What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 92.
best — the order this archive was captured in
Asked 13 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
[deleted]
Yeah, 503A and 503B are different regulatory animals.
Asked 13 compounders about API source.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
state board rules differ, say which state
Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.
Flair changed to match the content. Read the sidebar before posting next time and we are square.
regulatory claims need a citation to the actual rule, not interpretation
Strongly agree. API source transparency matters.
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
Yeah, 503A and 503B are different regulatory animals.
Strongly agree. API source transparency matters.
no pharmacy referral codes, naming is fine, recruiting is not
Respectfully this is a sample of one presented as a finding.
the Sweden situation is different from the US, different regulations
The telehealth + compounding combo cost API source plus 21% markup. Not cheap but covered by insurance depending on state.
Not convinced. The evidence does not support that reading.
no pharmacy referral codes, naming is fine, recruiting is not
Slight fix: the number was 93.7, not 99.3. Decimal point, but a fairly consequential one.
Strongly agree. API source transparency matters.
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
the 503A/503B distinction is load-bearing, do not blur it
API source questions are on-topic and compounders dodging them is newsworthy
The telehealth + compounding combo cost telehealth plus 12% markup. Not cheap but covered by insurance depending on state.
- 1Asked 13 compounders about API source. One told me, one dodged, one said…9 comments in this branch · started by u/mateusz_adebayo
- 2Yeah, 503A and 503B are different regulatory animals.9 comments in this branch · started by u/camila_sandvik